306 related articles for article (PubMed ID: 29393039)
1. Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.
Ranjan A
Dan Med J; 2018 Feb; 65(2):. PubMed ID: 29393039
[TBL] [Abstract][Full Text] [Related]
2. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
3. Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study.
Ranjan A; Schmidt S; Damm-Frydenberg C; Steineck I; Clausen TR; Holst JJ; Madsbad S; Nørgaard K
Diabetes Care; 2017 Jan; 40(1):132-135. PubMed ID: 27797928
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
[TBL] [Abstract][Full Text] [Related]
6. Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
Ranjan A; Nørgaard K; Tetzschner R; Steineck IIK; Clausen TR; Holst JJ; Madsbad S; Schmidt S
Diabetes Care; 2018 Apr; 41(4):797-806. PubMed ID: 29358493
[TBL] [Abstract][Full Text] [Related]
7. Efficacy determinants of subcutaneous microdose glucagon during closed-loop control.
Russell SJ; El-Khatib FH; Nathan DM; Damiano ER
J Diabetes Sci Technol; 2010 Nov; 4(6):1288-304. PubMed ID: 21129323
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the effectiveness of glucagon for preventing hypoglycemia.
Castle JR; Engle JM; El Youssef J; Massoud RG; Ward WK
J Diabetes Sci Technol; 2010 Nov; 4(6):1305-10. PubMed ID: 21129324
[TBL] [Abstract][Full Text] [Related]
9. Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
Rickels MR; DuBose SN; Toschi E; Beck RW; Verdejo AS; Wolpert H; Cummins MJ; Newswanger B; Riddell MC;
Diabetes Care; 2018 Sep; 41(9):1909-1916. PubMed ID: 29776987
[TBL] [Abstract][Full Text] [Related]
10. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
Bally L; Thabit H; Hovorka R
Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
[No Abstract] [Full Text] [Related]
11. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
[TBL] [Abstract][Full Text] [Related]
14. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
[TBL] [Abstract][Full Text] [Related]
15. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
[TBL] [Abstract][Full Text] [Related]
16. Current view of treatment of hypoglycemia.
Brož J; Urbanová J; Nunes M; Tuháčková M; Brunerová L; Žďárská DJ
Vnitr Lek; 2019; 65(4):295-299. PubMed ID: 31091950
[TBL] [Abstract][Full Text] [Related]
17. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
18. Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.
Reiband HK; Schmidt S; Ranjan A; Holst JJ; Madsbad S; Nørgaard K
Diabetes Metab Res Rev; 2015 Oct; 31(7):672-9. PubMed ID: 25533565
[TBL] [Abstract][Full Text] [Related]
19. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.
Haymond MW; Schreiner B
Diabetes Care; 2001 Apr; 24(4):643-5. PubMed ID: 11315823
[TBL] [Abstract][Full Text] [Related]
20. Early insulin: an important therapeutic strategy.
Dailey GE
Diabetes Care; 2005 Jan; 28(1):220-1. PubMed ID: 15616256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
